These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A common variant in PNPLA3 is associated with age at diagnosis of NAFLD in patients from a multi-ethnic biobank. Walker RW; Belbin GM; Sorokin EP; Van Vleck T; Wojcik GL; Moscati A; Gignoux CR; Cho J; Abul-Husn NS; Nadkarni G; Kenny EE; Loos RJF J Hepatol; 2020 Jun; 72(6):1070-1081. PubMed ID: 32145261 [TBL] [Abstract][Full Text] [Related]
3. Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort Anstee QM; Darlay R; Cockell S; Meroni M; Govaere O; Tiniakos D; Burt AD; Bedossa P; Palmer J; Liu YL; Aithal GP; Allison M; Yki-Järvinen H; Vacca M; Dufour JF; Invernizzi P; Prati D; Ekstedt M; Kechagias S; Francque S; Petta S; Bugianesi E; Clement K; Ratziu V; Schattenberg JM; Valenti L; Day CP; Cordell HJ; Daly AK; J Hepatol; 2020 Sep; 73(3):505-515. PubMed ID: 32298765 [TBL] [Abstract][Full Text] [Related]
4. Genetic Polymorphisms of PNPLA3 and SAMM50 Are Associated with Nonalcoholic Fatty Liver Disease in a Korean Population. Chung GE; Lee Y; Yim JY; Choe EK; Kwak MS; Yang JI; Park B; Lee JE; Kim JA; Kim JS Gut Liver; 2018 May; 12(3):316-323. PubMed ID: 29271184 [TBL] [Abstract][Full Text] [Related]
5. Genome-wide scan revealed that polymorphisms in the PNPLA3, SAMM50, and PARVB genes are associated with development and progression of nonalcoholic fatty liver disease in Japan. Kitamoto T; Kitamoto A; Yoneda M; Hyogo H; Ochi H; Nakamura T; Teranishi H; Mizusawa S; Ueno T; Chayama K; Nakajima A; Nakao K; Sekine A; Hotta K Hum Genet; 2013 Jul; 132(7):783-92. PubMed ID: 23535911 [TBL] [Abstract][Full Text] [Related]
6. Effects of PNPLA3, TM6SF2 and SAMM50 on the development and severity of non-alcoholic fatty liver disease in children. Lee KJ; Moon JS; Kim NY; Ko JS Pediatr Obes; 2022 Feb; 17(2):e12852. PubMed ID: 34490745 [TBL] [Abstract][Full Text] [Related]
8. Association of the rs738409 polymorphism in PNPLA3 with liver damage and the development of nonalcoholic fatty liver disease. Hotta K; Yoneda M; Hyogo H; Ochi H; Mizusawa S; Ueno T; Chayama K; Nakajima A; Nakao K; Sekine A BMC Med Genet; 2010 Dec; 11():172. PubMed ID: 21176169 [TBL] [Abstract][Full Text] [Related]
9. The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease. Rotman Y; Koh C; Zmuda JM; Kleiner DE; Liang TJ; Hepatology; 2010 Sep; 52(3):894-903. PubMed ID: 20684021 [TBL] [Abstract][Full Text] [Related]
10. Carriage of the PNPLA3 rs738409 C >G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma. Liu YL; Patman GL; Leathart JB; Piguet AC; Burt AD; Dufour JF; Day CP; Daly AK; Reeves HL; Anstee QM J Hepatol; 2014 Jul; 61(1):75-81. PubMed ID: 24607626 [TBL] [Abstract][Full Text] [Related]
11. Association of PNPLA3 rs738409 G/C gene polymorphism with nonalcoholic fatty liver disease in children: a meta-analysis. Tang S; Zhang J; Mei TT; Guo HQ; Wei XH; Zhang WY; Liu YL; Liang S; Fan ZP; Ma LX; Lin W; Liu YR; Qiu LX; Yu HB BMC Med Genet; 2020 Aug; 21(1):163. PubMed ID: 32811452 [TBL] [Abstract][Full Text] [Related]
12. Linked PNPLA3 polymorphisms confer susceptibility to nonalcoholic steatohepatitis and decreased viral load in chronic hepatitis B. Pan Q; Zhang RN; Wang YQ; Zheng RD; Mi YQ; Liu WB; Shen F; Chen GY; Lu JF; Zhu CY; Zhang SY; Chen YM; Sun WL; Fan JG World J Gastroenterol; 2015 Jul; 21(28):8605-14. PubMed ID: 26229402 [TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphisms of the human PNPLA3 gene are strongly associated with severity of non-alcoholic fatty liver disease in Japanese. Kawaguchi T; Sumida Y; Umemura A; Matsuo K; Takahashi M; Takamura T; Yasui K; Saibara T; Hashimoto E; Kawanaka M; Watanabe S; Kawata S; Imai Y; Kokubo M; Shima T; Park H; Tanaka H; Tajima K; Yamada R; Matsuda F; Okanoue T; PLoS One; 2012; 7(6):e38322. PubMed ID: 22719876 [TBL] [Abstract][Full Text] [Related]
14. Genetic variants in COL13A1, ADIPOQ and SAMM50, in addition to the PNPLA3 gene, confer susceptibility to elevated transaminase levels in an admixed Mexican population. Larrieta-Carrasco E; Flores YN; Macías-Kauffer LR; Ramírez-Palacios P; Quiterio M; Ramírez-Salazar EG; León-Mimila P; Rivera-Paredez B; Cabrera-Álvarez G; Canizales-Quinteros S; Zhang ZF; López-Pérez TV; Salmerón J; Velázquez-Cruz R Exp Mol Pathol; 2018 Feb; 104(1):50-58. PubMed ID: 29307798 [TBL] [Abstract][Full Text] [Related]
15. Association of metabolic syndrome and patatin-like phospholipase 3 - rs738409 gene variant in non-alcoholic fatty liver disease among a Chennai-based south Indian population. Narayanasamy K; Karthick R; Panneerselvam P; Mohan N; Ramachandran A; Prakash R; Rajaram M J Gene Med; 2020 Apr; 22(4):e3160. PubMed ID: 31945251 [TBL] [Abstract][Full Text] [Related]
16. APOC3 rs2070666 Is Associated with the Hepatic Steatosis Independently of PNPLA3 rs738409 in Chinese Han Patients with Nonalcoholic Fatty Liver Diseases. Zhang RN; Zheng RD; Mi YQ; Zhou D; Shen F; Chen GY; Zhu CY; Pan Q; Fan JG Dig Dis Sci; 2016 Aug; 61(8):2284-2293. PubMed ID: 27059980 [TBL] [Abstract][Full Text] [Related]
17. Genome-Wide Association Study of NAFLD Using Electronic Health Records. Fairfield CJ; Drake TM; Pius R; Bretherick AD; Campbell A; Clark DW; Fallowfield JA; Hayward C; Henderson NC; Joshi PK; Mills NL; Porteous DJ; Ramachandran P; Semple RK; Shaw CA; Sudlow CLM; Timmers PRHJ; Wilson JF; Wigmore SJ; Harrison EM; Spiliopoulou A Hepatol Commun; 2022 Feb; 6(2):297-308. PubMed ID: 34535985 [TBL] [Abstract][Full Text] [Related]
18. Role of the PNPLA3 I148M polymorphism in nonalcoholic fatty liver disease and fibrosis in Korea. Lee SS; Byoun YS; Jeong SH; Woo BH; Jang ES; Kim JW; Kim HY Dig Dis Sci; 2014 Dec; 59(12):2967-74. PubMed ID: 25069572 [TBL] [Abstract][Full Text] [Related]
19. Targeted next-generation sequencing and fine linkage disequilibrium mapping reveals association of PNPLA3 and PARVB with the severity of nonalcoholic fatty liver disease. Kitamoto T; Kitamoto A; Yoneda M; Hyogo H; Ochi H; Mizusawa S; Ueno T; Nakao K; Sekine A; Chayama K; Nakajima A; Hotta K J Hum Genet; 2014 May; 59(5):241-6. PubMed ID: 24621583 [TBL] [Abstract][Full Text] [Related]
20. A GWAS Study on Liver Function Test Using eMERGE Network Participants. Namjou B; Marsolo K; Lingren T; Ritchie MD; Verma SS; Cobb BL; Perry C; Kitchner TE; Brilliant MH; Peissig PL; Borthwick KM; Williams MS; Grafton J; Jarvik GP; Holm IA; Harley JB PLoS One; 2015; 10(9):e0138677. PubMed ID: 26413716 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]